S&P 500   3,945.57 (+0.74%)
DOW   32,194.92 (+1.04%)
QQQ   304.88 (-0.16%)
AAPL   157.34 (+1.51%)
MSFT   270.64 (-3.15%)
META   197.47 (+0.95%)
GOOGL   101.19 (-0.42%)
AMZN   97.02 (-1.95%)
TSLA   183.10 (+1.65%)
NVDA   258.05 (+0.31%)
NIO   8.69 (+5.21%)
BABA   80.74 (-1.14%)
AMD   96.15 (-1.73%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.14 (+0.85%)
CGC   1.87 (-6.50%)
GE   89.61 (-0.75%)
DIS   93.72 (+0.56%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.70 (-0.40%)
NFLX   303.72 (+0.07%)
S&P 500   3,945.57 (+0.74%)
DOW   32,194.92 (+1.04%)
QQQ   304.88 (-0.16%)
AAPL   157.34 (+1.51%)
MSFT   270.64 (-3.15%)
META   197.47 (+0.95%)
GOOGL   101.19 (-0.42%)
AMZN   97.02 (-1.95%)
TSLA   183.10 (+1.65%)
NVDA   258.05 (+0.31%)
NIO   8.69 (+5.21%)
BABA   80.74 (-1.14%)
AMD   96.15 (-1.73%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.14 (+0.85%)
CGC   1.87 (-6.50%)
GE   89.61 (-0.75%)
DIS   93.72 (+0.56%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.70 (-0.40%)
NFLX   303.72 (+0.07%)
S&P 500   3,945.57 (+0.74%)
DOW   32,194.92 (+1.04%)
QQQ   304.88 (-0.16%)
AAPL   157.34 (+1.51%)
MSFT   270.64 (-3.15%)
META   197.47 (+0.95%)
GOOGL   101.19 (-0.42%)
AMZN   97.02 (-1.95%)
TSLA   183.10 (+1.65%)
NVDA   258.05 (+0.31%)
NIO   8.69 (+5.21%)
BABA   80.74 (-1.14%)
AMD   96.15 (-1.73%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.14 (+0.85%)
CGC   1.87 (-6.50%)
GE   89.61 (-0.75%)
DIS   93.72 (+0.56%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.70 (-0.40%)
NFLX   303.72 (+0.07%)
S&P 500   3,945.57 (+0.74%)
DOW   32,194.92 (+1.04%)
QQQ   304.88 (-0.16%)
AAPL   157.34 (+1.51%)
MSFT   270.64 (-3.15%)
META   197.47 (+0.95%)
GOOGL   101.19 (-0.42%)
AMZN   97.02 (-1.95%)
TSLA   183.10 (+1.65%)
NVDA   258.05 (+0.31%)
NIO   8.69 (+5.21%)
BABA   80.74 (-1.14%)
AMD   96.15 (-1.73%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.14 (+0.85%)
CGC   1.87 (-6.50%)
GE   89.61 (-0.75%)
DIS   93.72 (+0.56%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.70 (-0.40%)
NFLX   303.72 (+0.07%)
OTCMKTS:XSNX

NovAccess Global - XSNX Stock Forecast, Price & News

$0.24
+0.07 (+39.41%)
(As of 03/17/2023 08:55 PM ET)
Add
Compare
Today's Range
$0.17
$0.24
50-Day Range
$0.14
$0.25
52-Week Range
$0.10
$0.60
Volume
17,100 shs
Average Volume
8,707 shs
Market Capitalization
$4.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

XSNX stock logo

About NovAccess Global (OTCMKTS:XSNX) Stock

NovAccess Global, Inc. is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in Cuyahoga County, OH.

Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

XSNX Stock News Headlines

The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
NovAccess Global to Present at World Orphan Drug Congress
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
XSNX NovAccess Global Inc.
XSNX NovAccess Global Inc.
NovAccess Global Inc
NovAccess Global Announces Uplisting to OTCQB
See More Headlines
Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

XSNX Company Calendar

Today
3/20/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:XSNX
Employees
2
Year Founded
N/A

Profitability

Net Income
$-1,720,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.50) per share

Miscellaneous

Free Float
20,674,000
Market Cap
$4.97 million
Optionable
Not Optionable
Beta
1.63

Key Executives

  • Dwain Morris-Irvin
    Chief Executive Officer
  • Neil J. Laird
    Chief Financial Officer













XSNX Stock - Frequently Asked Questions

How have XSNX shares performed in 2023?

NovAccess Global's stock was trading at $0.29 on January 1st, 2023. Since then, XSNX stock has decreased by 18.3% and is now trading at $0.2370.
View the best growth stocks for 2023 here
.

Are investors shorting NovAccess Global?

NovAccess Global saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 3,600 shares, a decrease of 52.6% from the February 13th total of 7,600 shares. Based on an average trading volume of 6,200 shares, the days-to-cover ratio is presently 0.6 days.
View NovAccess Global's Short Interest
.

What other stocks do shareholders of NovAccess Global own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NovAccess Global investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN), Ascent Solar Technologies (ASTI) and BioRestorative Therapies (BRTX).

What is NovAccess Global's stock symbol?

NovAccess Global trades on the OTCMKTS under the ticker symbol "XSNX."

How do I buy shares of NovAccess Global?

Shares of XSNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NovAccess Global's stock price today?

One share of XSNX stock can currently be purchased for approximately $0.24.

How much money does NovAccess Global make?

NovAccess Global (OTCMKTS:XSNX) has a market capitalization of $4.97 million.

How can I contact NovAccess Global?

NovAccess Global's mailing address is 8834 MAYFIELD RD, CHESTERLAND OH, 44026. The official website for the company is www.xsunx.com. The company can be reached via phone at (213) 642-9268, via email at investors@xsunx.com, or via fax at 949-266-5823.

This page (OTCMKTS:XSNX) was last updated on 3/20/2023 by MarketBeat.com Staff